Assignee profile:

AMAZENTIS SA

City:

Lausanne

Country:

Switzerland

Published Applications:

21

Last publication date:

2025-12-11

Patent Grants:

21

Last grant date:

2026-03-17

Top Inventors for applications by AMAZENTIS SA

These are the the leading inventors for applications assigned to AMAZENTIS SA:

Recent patent applications by AMAZENTIS SA

AMAZENTIS SA based in Lausanne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-11 ✅ Patent 12,576,064 granted on 2026-03-17
US20250375412A1
Human necessities

UROLITHIN GUMMY (PECTIN) FORMULATIONS

#2 | 2025-07-17 ✅ Patent 12,576,065 granted on 2026-03-17
US20250228816A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#3 | 2024-05-09 ✅ Patent 12,297,182 granted on 2025-05-13
US20240150310A1
Chemistry; metallurgy

Compositions comprising an urolithin compound

#4 | 2024-03-28 ✅ Patent 12,310,943 granted on 2025-05-27
US20240100016A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#5 | 2023-11-09 ✅ Patent 12,338,224 granted on 2025-06-24
US20230357176A1
Chemistry; metallurgy

PROCESS-SCALE SYNTHESIS OF UROLITHIN A

#6 | 2023-07-27 ✅ Patent 12,544,358 granted on 2026-02-10
US20230233523A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#7 | 2023-03-30 ✅ Patent 12,109,190 granted on 2024-10-08
US20230097072A1
Human necessities

Urolithins as immune response enhancers

#8 | 2022-10-13 ✅ Patent 11,925,616 granted on 2024-03-12
US20220323407A1
Human necessities

Compositions comprising urolithin compounds

#9 | 2022-09-08 ✅ Patent 12,036,205 granted on 2024-07-16
US20220280475A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#10 | 2022-04-28 ✅ Patent 12,030,863 granted on 2024-07-09
US20220127240A1
Chemistry; metallurgy

Prodrugs of urolithins and uses thereof

#11 | 2022-04-07 ✅ Patent 12,220,424 granted on 2025-02-11
US20220105117A1
Human necessities

Compositions comprising nicotinamide riboside and a urolithin

#12 | 2022-03-10 ✅ Patent 11,878,964 granted on 2024-01-23
US20220073488A1
Chemistry; metallurgy

Compositions comprising an urolithin compound

#13 | 2021-11-18 ✅ Patent 11,931,336 granted on 2024-03-19
US20210353591A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins

#14 | 2021-07-01 ✅ Patent 11,634,401 granted on 2023-04-25
US20210198225A1
Chemistry; metallurgy

Process-scale synthesis of urolithin A

#15 | 2021-03-25 ✅ Patent 11,426,380 granted on 2022-08-30
US20210085642A1
Human necessities

Urolithins as immune response enhancers

#16 | 2021-03-04 ✅ Patent 11,903,922 granted on 2024-02-20
US20210059982A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#17 | 2020-12-24 ✅ Patent 11,931,335 granted on 2024-03-19
US20200397748A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

#18 | 2020-10-15 ✅ Patent 11,337,957 granted on 2022-05-24
US20200323818A1
Human necessities

Compositions comprising urolithin compounds

#19 | 2018-09-13 ✅ Patent 11,969,408 granted on 2024-04-30
US20180256539A1
Human necessities

Method for improving mitophagy in subjects

#20 | 2016-11-17 ✅ Patent 9,994,542 granted on 2018-06-12
US20160332982A1
Chemistry; metallurgy

Prodrugs of urolithins and uses thereof

#21 | 2016-07-28 ✅ Patent 11,234,960 granted on 2022-02-01
US20160213643A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

Also check out Amazentis SA's (Lausanne, Switzerland) applicant profile with 30 patent applications submitted.

AssigneeID:

115648 ⎘